320 related articles for article (PubMed ID: 25266896)
1. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.
Yu S; Khor TO; Cheung KL; Li W; Wu TY; Huang Y; Foster BA; Kan YW; Kong AN
PLoS One; 2010 Jan; 5(1):e8579. PubMed ID: 20062804
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
[TBL] [Abstract][Full Text] [Related]
5. A γ-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation.
Huang Y; Khor TO; Shu L; Saw CL; Wu TY; Suh N; Yang CS; Kong AN
J Nutr; 2012 May; 142(5):818-23. PubMed ID: 22457388
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation.
Su ZY; Khor TO; Shu L; Lee JH; Saw CL; Wu TY; Huang Y; Suh N; Yang CS; Conney AH; Wu Q; Kong AN
Chem Res Toxicol; 2013 Mar; 26(3):477-85. PubMed ID: 23441843
[TBL] [Abstract][Full Text] [Related]
7. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
8. The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP-C1 prostate cells.
Yang J; Wu R; Li W; Gao L; Yang Y; Li P; Kong AN
Mol Carcinog; 2018 Apr; 57(4):512-521. PubMed ID: 29247555
[TBL] [Abstract][Full Text] [Related]
9. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation.
Khor TO; Huang Y; Wu TY; Shu L; Lee J; Kong AN
Biochem Pharmacol; 2011 Nov; 82(9):1073-8. PubMed ID: 21787756
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.
Zhang C; Su ZY; Khor TO; Shu L; Kong AN
Biochem Pharmacol; 2013 May; 85(9):1398-404. PubMed ID: 23416117
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells.
Shu L; Khor TO; Lee JH; Boyanapalli SS; Huang Y; Wu TY; Saw CL; Cheung KL; Kong AN
AAPS J; 2011 Dec; 13(4):606-14. PubMed ID: 21938566
[TBL] [Abstract][Full Text] [Related]
13. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells.
Li W; Su ZY; Guo Y; Zhang C; Wu R; Gao L; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2018 Feb; 31(2):88-96. PubMed ID: 29228771
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
16. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
Schayek H; Bentov I; Sun S; Plymate SR; Werner H
Exp Cell Res; 2010 May; 316(9):1479-88. PubMed ID: 20338164
[TBL] [Abstract][Full Text] [Related]
17. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.
Shinojima T; Yu Q; Huang SK; Li M; Mizuno R; Liu ET; Hoon DS; Lessard L
Epigenetics; 2012 Nov; 7(11):1279-89. PubMed ID: 23023649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
